drugset / Trial / NCT02331134
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
NaSingle-groupOpen-labelBasic science
Summary
The overall goal of this study is to develop a pre-clinical platform of melanoma and head and neck squamous cell cancer that will allow the investigators to learn more about these diseases and discover better and more individualized treatments.
Timeline
- Start
- 2015-05-13
- Primary completion
- 2018-07-06
- Completion
- 2025-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | filgrastim | Protein / enzyme biologic | 10 ug/kg | Subcutaneous |